Apellis Pharmaceuticals Inc (NASDAQ: APLS) is -42.65% lower on its value in year-to-date trading and has touched a low of $16.10 and a high of $43.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APLS stock was last observed hovering at around $18.83 in the last trading session, with the day’s loss setting it -0.53%.
Currently trading at $18.30, the stock is -0.09% and -0.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.81 million and changing -2.81% at the moment leaves the stock -32.13% off its SMA200. APLS registered -56.94% loss for a year compared to 6-month loss of -46.18%.
The stock witnessed a 11.86% gain in the last 1 month and extending the period to 3 months gives it a -27.12%, and is -5.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.21% over the week and 3.85% over the month.
Apellis Pharmaceuticals Inc (APLS) has around 710 employees, a market worth around $2.30B and $775.84M in sales. Profit margin for the company is -28.83%. Distance from 52-week low is 13.66% and -57.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.68%).
The EPS is expected to shrink by -21.78% this year.
Apellis Pharmaceuticals Inc (APLS) Top Institutional Holders
The shares outstanding are 125.66M, and float is at 103.36M with Short Float at 24.22%.
The top institutional shareholder in the company is WELLINGTON MANAGEMENT GROUP LLP with over 16.39 million shares valued at $628.67 million. The investor’s holdings represent 13.2269% of the APLS Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 11.61 million shares valued at $445.26 million to account for 9.3681 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 11.11 million shares representing 8.9675% and valued at over $426.22 million, while VANGUARD GROUP INC holds 7.9171 of the shares totaling 9.81 million with a market value of $376.29 million.
Apellis Pharmaceuticals Inc (APLS) Insider Activity
#####
Still, SEC filings show that on Mar 17 ’25, Chopas James George (VP/Chief Accounting Officer) disposed off 183 shares at an average price of $24.82 for $4543.0. The insider now directly holds 47,955 shares of Apellis Pharmaceuticals Inc (APLS).
